Ovarian Cancer Clinical Trials

There are 33 registered clinical trials for Ovarian Cancer in the TrialLens index.

Trials (33)

Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer Phase 2 · Gynecologic Oncology Group
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors Phase 2 · Hoffmann-La Roche
Exercise and Nutrition Intervention in Ovarian Cancer N/A · Universitätsklinikum Hamburg-Eppendorf
Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer N/A · Complejo Hospitalario Universitario Insular Materno Infantil
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Phase 2/3 · Ludwig-Maximilians - University of Munich
Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer N/A · University Hospital, Grenoble
Innovative Ovarian Cancer Biomarker Assays N/A · National and Kapodistrian University of Athens
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy Phase 2 · Neovii Biotech
Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact N/A · Milton S. Hershey Medical Center
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer Phase 4 · Shandong University
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy Phase 2 · NewVac LLC
The Registry of Genetic Alterations of Taiwan Ovarian Cancer N/A · National Health Research Institutes, Taiwan
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer Phase 1 · M.D. Anderson Cancer Center
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. N/A · British Columbia Cancer Agency
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer Phase 2 · NCIC Clinical Trials Group
Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients Phase 3 · University College, London
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer N/A · Children's Oncology Group
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery Phase 1 · Steven Waggoner, MD
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Phase 2 · Memorial Sloan Kettering Cancer Center
Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification N/A · University of Alabama at Birmingham
BrUOG 390: Neoadjuvant Treatment With Talazoparib Phase 1 · Brown University
A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Phase 1 · Boryung Pharmaceutical Co., Ltd
Asian Multicenter Prospective Study of ctDNA Sequencing N/A · National Cancer Center, Japan
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer N/A · National Cancer Center, Korea
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors N/A · Peking University First Hospital
Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy N/A · Universidade Federal de Goias
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma Phase 2 · Eastern Cooperative Oncology Group
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence N/A · Peking Union Medical College Hospital
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer Phase 2 · Gynecologic Oncology Group
89Zr-DFO-Mirvetuximab PET/CT Imaging for Companion Diagnosis and Response Evaluation in Ovarian Cancer Early Phase 1 · Peking University Cancer Hospital & Institute
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers Phase 1 · Arcus Biosciences, Inc.
A Phase 1 Study of LNCB74 in Advanced Solid Tumors Phase 1 · LigaChem Biosciences, Inc.
Engineered Immune Effectors Against Ovarian Cancer Phase 1/2 · Shenzhen Geno-Immune Medical Institute

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.